AstraZeneca AB
AstraZeneca AB, a leading global biopharmaceutical company, is headquartered in Sweden (SE) and operates extensively across Europe, North America, and Asia. Founded in 1999 through the merger of Astra AB and Zeneca Group, the company has since established itself as a key player in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular, renal, and respiratory diseases. AstraZeneca is renowned for its commitment to research and development, with a robust pipeline of unique therapies that address unmet medical needs. Notable achievements include the rapid development of its COVID-19 vaccine, which showcased the company's agility and dedication to public health. With a strong market position, AstraZeneca continues to drive advancements in healthcare, making significant contributions to patient outcomes worldwide.
DitchCarbon Score
How does AstraZeneca AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AstraZeneca AB's score of 60 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AstraZeneca AB's reported carbon emissions
AstraZeneca AB, headquartered in Sweden (SE), currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is challenging to assess their direct impact on climate change through emissions. However, the company is likely engaged in various climate commitments and initiatives typical of the pharmaceutical industry, focusing on sustainability and reducing environmental footprints. As the industry increasingly prioritises climate action, AstraZeneca may be aligning with global standards and frameworks, such as the Science Based Targets initiative (SBTi), to enhance their climate strategies. While specific details on their emissions or targets are not disclosed, the company’s commitment to sustainability is expected to reflect broader industry trends towards achieving net-zero emissions and enhancing environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AstraZeneca AB is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
